Search Browse Earnings

Erasca, Inc. — SlamSEC

Erasca, Inc.

Nasdaq:ERAS

Pharmaceutical Preparations·SAN DIEGO, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

—

Adj. EBITDA

-$175.8M

FY 2025

Net Income

-$161.7M

FY 2025

EPS (Diluted)

-$0.69

FY 2025

Stock Price

$14.28

-7.9%

2026-03-13

52W Range

$1.01 – $16.41

P/E Ratio

-20.7x

Market Cap

$4.4B

Cash

$67.7M

FY 2025

Total Debt

—

Net Cash

$67.7M

Enterprise Value

$4.4B

Debt / EBITDA

0.4x

FY 2025

EV / EBITDA

-24.9x

Employees

—